Sigma Planning Corp Editas Medicine, Inc. Transaction History

Sigma Planning Corp

$3.11 Billion
Q1 2024

A detailed history of Sigma Planning Corp transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 13,290 shares of EDIT stock, worth $67,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,290

Holding current value

$67,513

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$7.03 - $11.07 $93,428 - $147,120	13,290 New	13,290 $98,000
Q3 2023 Nov 06, 2023	SELL	$6.92 - $9.31 $2,830 - $3,807	-409 Reduced 2.73%	14,558 $113,000
Q2 2023 Aug 01, 2023	BUY	$6.36 - $11.47 $2,524 - $4,553	397 Added 2.72%	14,967 $123,000
Q1 2023 May 05, 2023	BUY	$7.03 - $11.53 $13,117 - $21,514	1,866 Added 14.69%	14,570 $105,000
Q4 2022 Jan 24, 2023	SELL	$8.32 - $13.21 $32,539 - $51,664	-3,911 Reduced 23.54%	12,704 $0

Q3 2022 Nov 10, 2022	SELL	$12.16 - $19.42 $5,399 - $8,622	-444 Reduced 2.6%	16,615 $203,000
Q2 2022 Aug 11, 2022	BUY	$9.99 - $21.35 $21,848 - $46,692	2,187 Added 14.71%	17,059 $202,000
Q1 2022 Apr 20, 2022	BUY	$14.08 - $27.63 $49,054 - $96,262	3,484 Added 30.59%	14,872 $283,000
Q4 2021 Feb 02, 2022	BUY	$26.55 - $40.57 $10,168 - $15,538	383 Added 3.48%	11,388 $302,000
Q3 2021 Oct 28, 2021	BUY	$39.27 - $72.94 $154,880 - $287,675	3,944 Added 55.86%	11,005 $452,000
Q2 2021 Aug 13, 2021	BUY	$31.29 - $56.64 $220,938 - $399,935	7,061 New	7,061 $400,000
Q1 2021 May 06, 2021	SELL	$39.71 - $90.58 $160,348 - $365,762	-4,038 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$27.07 - $84.35 $109,308 - $340,605	4,038 New	4,038 $283,000
Q3 2018 Nov 07, 2018	SELL	$27.65 - $38.39 $179,918 - $249,803	-6,507 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$31.4 - $41.01 $1,350 - $1,763	-43 Reduced 0.66%	6,507 $233,000
Q1 2018 May 11, 2018	BUY	$29.84 - $44.08 $195,452 - $288,724	6,550 New	6,550 $217,000

Others Institutions Holding EDIT

# of Institutions

244

Shares Held

69.3M

Call Options Held

564K

Put Options Held

428K

State Street Corp Boston, MA

8.76M
Shares

$44.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.56M
Shares

$43.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.83M
Shares

$39.8 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.53M
Shares

$28.1 Million
1.35% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.61M
Shares

$13.2 Million
0.01% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $349M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account